Clinical Trials Browser

Phase 1/2 × Doxycycline × Dermatologic × Clear all

NCT01590082 2020-09-02

Doxycycline, Temozolomide and Ipilimumab in Melanoma

Phase 1/2 Terminated

12 enrolled 6 charts

Melanoma